论文部分内容阅读
波兰学者对颗粒状丙酸杆菌 Kp45(PG)已经进行了七年实验和临床研究,证明对于巨噬细胞-单核细胞系统有很强的刺激作用,若配合化疗可降低骨髓毒性,局部注射可使肿瘤缩小。本文评价了79例小细胞肺癌联合化疗或加免疫治疗的随机分组结果。病例选择条件是:肿瘤病灶能测量或可评价,年龄在70岁以下,一般状况按 Karnofsky 评分标准在50分以上,白细胞数>2×10~9/升,血小板数>100×10~9/升。两组患者例数、年龄范围、总的临床状况、病程和转移灶的分布均相同。
Polish scholars have conducted experimental and clinical studies on the particulate propionic acid-producing Kp45 (PG) for seven years, demonstrating a strong stimulatory effect on the macrophage-monocyte system. If combined with chemotherapy can reduce bone marrow toxicity, local injection can be Make the tumor shrink. This article evaluated the randomized grouping of 79 cases of small cell lung cancer combined with chemotherapy or immunotherapy. Case selection criteria are: tumor lesions can be measured or can be evaluated, age is under 70 years old, general condition is above 50 points according to Karnofsky criteria, white blood cell count is >2×10-9/l, platelet count is >100×10-9/ Rise. The number of cases, age range, total clinical condition, course of disease, and distribution of metastases were the same in both groups.